title: Inhibitory effect of the nonpeptide angiotensin II receptor antagonist losartan and its active metabolite, E-3174, on cAMP phosphodiesterase: additional action of the antagonists.
abstract: The inhibitory effects of the nonpeptide angiotensin II (AII) receptor antagonist losartan and its active metabolite, E-3174, on bovine brain calcium/calmodulin-dependent 3':5'-cyclic nucleotide phosphodiesterase (cAMP PDE) were investigated. Losartan and E-3174 inhibited cAMP PDE activity competitively with an apparent Ki of 18.7 +/- 2 microM (N = 3) and 70.4 +/- 8 microM (N = 3) with respect to cAMP, respectively. With 1.2 mM cAMP as a substrate, cAMP PDE activities were inhibited by losartan and E-3174 in a concentration-dependent manner. The concentrations of losartan and E-3174 required to obtain 50% inhibition of the enzyme activity (IC50) were estimated to be 38.9 +/- 7 microM (N = 3) and 139.3 +/- 39 microM (N = 3), respectively. These results show that losartan is about four times more potent than E-3174 in inhibiting the enzyme. The Hill coefficient of -1.0 +/- -0.04 (N = 3) for losartan and -1.1 +/- -0.14 (N = 3) for E-3174 was obtained, indicating that one inhibitor binding site is available on cAMP PDE. This study demonstrated that losartan and E-3174 exert additional inhibitory action on cAMP PDE besides AII receptor antagonism.
authors.affiliation: Department of Drug Metabolism, Banyu Pharmaceutical Co., Ltd., Saitama, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Ishizaki
authors.forename: M
authors.initials: M
authors.lastname: Ohtawa
mesh_terms: D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000037:antagonists & inhibitors*; D057911:Angiotensin Receptor Antagonists; D000818:Animals; D000959:Antihypertensive Agents / Q000037:antagonists & inhibitors*; D001713:Biphenyl Compounds / Q000494:pharmacology*; D001921:Brain / Q000201:enzymology; D002417:Cattle; D007093:Imidazoles / Q000494:pharmacology*; D019808:Losartan; D013777:Tetrazoles / Q000494:pharmacology*
chemical_list: D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D001713:Biphenyl Compounds; D007093:Imidazoles; D013777:Tetrazoles; D015105:3',5'-Cyclic-AMP Phosphodiesterases; C066026:losartan carboxylic acid; D019808:Losartan